Neurological Institute Outcomes
Surgical Quality Improvement
Brain Tumor Surgery Outcomes
Brain Tumor Surgery ACS NSQIP Outcomes
January 1, 2021 – December 31, 2021
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall brain tumor surgery ACS NSQIP performance benchmarked against 207 participating sites.
|Brain Tumor (207 Sites)||N||Observed||Expected|
|30 Day Mortality||272||2.21%||2.77%|
|30 Day Morbidity||272||10.66%||10.02%|
|Deep Vein Thrombosis (DVT) / Pulmonary Embolus||272||6.25%||3.19%|
|Urinary Tract Infection (UTI)||272||0.37%||1.72%|
|Surgical Site Infection (SSI)||272||2.57%||1.87%|
|Return to Operating Room (ROR)||272||4.41%||4.55%|
American College of Surgeons National Surgical Quality Improvement Program, 2022.
ACS NSQIP® Semiannual Report July 12, 2022, Chicago: American College of Surgeons.